Adma Biologics (ADMA) Return on Sales [ROS] (2011 - 2026)
Adma Biologics (ADMA) recorded Return on Sales [ROS] of 42.16% in Q2 2026, up 7.08 percentage points from 35.08% a year earlier but down 8.74 percentage points from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) Return on Sales [ROS] (2011 - 2026) Analysis & Trends
On a TTM basis, Adma Biologics' Return on Sales [ROS] came in at 43.82% as of Jun 30, 2026, up 11.00 percentage points year-over-year; for FY2025, it came in at 37.53%, up 4.93 percentage points from FY2024.
- Annual Return on Sales [ROS] has increased for five straight years, with a five-year change of +191.28 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Sales [ROS] came in at 32.59% in FY2024 (+24.21 pp), 8.38% in FY2023 (+33.93 pp), -25.55% in FY2022 (+46.57 pp) and -72.12% in FY2021 (+81.64 pp).
- Quarterly Return on Sales [ROS] has ranged from -69.81% in Q3 2021 to 50.90% in Q1 2026 over the past five years.
- On a year-over-year basis, Return on Sales [ROS] has increased for four consecutive quarters, with an average year-over-year change of +10.10 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 73.39 percentage points in Q4 2021, against a drop of 1.49 percentage points in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at 50.90% (Q1 2026), 45.09% (Q4 2025) and 38.01% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 28.37% |
| 10 | Adma Biologics | 2.24 Bn | 1.81 Bn | 86.28 Mn | 42.16% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.16% |
| Mar 31, 2026 | 50.90% |
| Dec 31, 2025 | 45.09% |
| Sep 30, 2025 | 38.01% |
| Jun 30, 2025 | 35.08% |
| Mar 31, 2025 | 30.38% |
| Dec 31, 2024 | 32.60% |
| Sep 30, 2024 | 33.08% |
| Jun 30, 2024 | 36.57% |
| Mar 31, 2024 | 26.65% |
| Dec 31, 2023 | 19.26% |
| Sep 30, 2023 | 12.91% |
| Jun 30, 2023 | -0.79% |
| Mar 31, 2023 | -1.43% |
| Dec 31, 2022 | -12.12% |
| Sep 30, 2022 | -22.67% |
| Jun 30, 2022 | -27.06% |
| Mar 31, 2022 | -50.91% |
| Dec 31, 2021 | -50.00% |
| Sep 30, 2021 | -69.81% |
API Access
Adma Biologics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();